MUVON Therapeutics AG’s Post

View organization page for MUVON Therapeutics AG, graphic

2,284 followers

Excited to announce that Beatrix Rauch Schmid, one of our esteemed team members at MUVON, has been featured in the prestigious Globe Magazine of ETH Zurich! In this insightful article, ETH alumni share their valuable perspectives on innovation and the key factors driving success in today’s fast-paced world. Their dedication and expertise are a testament to the high standards and innovative spirit in Switzerland, that we strive to uphold at MUVON. https://lnkd.in/dx9rZKVG

Beatrix Rauch Schmid

Innovation Manager at MUVON Therapeutics AG

🌐 It was a great pleasure to give an interview for this inspiring article about how our fellow ETH Zürich alumni are driving innovation worldwide and boosting Switzerland’s innovation ecosystem. Check it out: https://lnkd.in/ds5-BcHi It is a great honor to be among these luminaries like Dominik Blunschy, Tilla Theus, Luca Di Tizio, Bigna Salzmann, Denniz Dönmez, PhD, Manuel Suter, Myke Näf, Oriana Kraft, Garif Yalak, Dr. sc. ETH, MBA HSG, Lukas Ambühl, Rea Sodero (Schegg). Let’s celebrate great achievements and the impact we’re making with all the other brilliant innovators among us! 💡 🌟 In my daily role at MUVON Therapeutics, I’m passionate about creating solutions that push boundaries and improve patients lives. 🚀 #ETHZurich #AlumniPride #StartupLife #Wysszurich #healthcareinnovation #Innovation #MedicalAdvancements #UZHinnovation

To view or add a comment, sign in

More Relevant Posts

Arumugham (Ragoo) Raghunathan

Personable Liaison to Drug Discovery via 3D Cell Culture | Passionate About Serving and Providing the Best Solutions | Business Development @ InSphero | Angel Investment | Connector | Influencer | Mentor | Career Coach
9mo
Report this post
Translation from Animals to Humans in Biomedical Research 🎙️ Talk Title: "Spheroids in Drug Development- An Emerging Technology Arrived in Routine" Join us at the workshop in Basel!

InSphero

11,590 followers
9mo

🌟 Fantastic News! We're delighted to share that Dr. Wolfgang Moritz, Head of External Collaborations & IP and Dr. Bärbel Ulmer, Business Development Manager will be attending the upcoming Advanced Drug Development Workshop in Basel. This event gathers experts from preclinical and clinical development to exchange insights on crafting effective clinical development strategies using innovative designs and integrating advanced technologies. Don't forget to catch Dr. Wolfgang Moritz presentation on Friday, October 6th, starting at 9:15 AM: 🗣️ Session Title: "Bridging the Gap: Translation from Animals to Humans in Biomedical Research" 🎙️ Talk Title: "Spheroids in Drug Development- An Emerging Technology Arrived in Routine" This presents a unique opportunity to explore the evolving landscape of drug development. We look forward to seeing you there! 👨🔬🧪 #DrugDevelopment #BiomedicalResearch #Innovation #ClinicalDevelopment #TheModelofExcellence ™ Christine Schwenk, Paul Edgard Clémençon, Arumugham (Ragoo) Raghunathan, Sue Grepper, PhD, Rositsa Hadzhipetrova, Tina Žel
Like Comment
To view or add a comment, sign in
CLINMARK - CONTRACT RESEARCH AND CONSULTING ORGANIZATION

3,241 followers
3mo
Report this post
🌟 Exciting News Alert! 🌟 Thrilled to announce that Zuzanna Szklarz and Dominika Kulpińska will be representing ClinMark at the prestigious Swiss Biotech Day! 🇨🇭 Join us at our stand for engaging discussions, networking opportunities, and to explore the latest advancements in clinical research. See you there! #SwissBiotechDay #ClinMark #ClinicalResearch #Networking #IndustryInsights

Swiss Biotech Day 2023 - Eventfilm

https://www.youtube.com/

2 Comments
Like Comment
To view or add a comment, sign in
TVM Capital Life Science

4,824 followers
8mo
Report this post
Does #Munich have the recipe for turning great science into great medicine? Yesterday, Dr. Hubert Birner, Managing Partner, TVM Capital Life Science, discussed the strength of the host city’s life sciences ecosystem in a panel with Laura A. Lane, Eli Lilly and Company; Heinrich Moisa, Novartis Deutschland and Ralf Huss, BioM Biotech Cluster Development GmbH. The session was moderated by Julia Groß, FOCUS MONEY. “I want to continue to build an industry in Germany. I think that’s what unites us in Munich. Together, we have an amazing density of players forming an outstanding life sciences ecosystem. Everybody needs to make a contribution to create a select number of long-lasting companies. No one can do it alone. Good things happen when you start to look outside the petri dish!” #BIOEurope #Collaboration #LifeSciences #InnovateOrDie!
1 Comment
Like Comment
To view or add a comment, sign in
Stefano Portolano, MD

Chief Executive Officer at AZAFAROS B.V.
3mo
Report this post
Looking forward to connecting with experts from >40 countries and discuss opportunities and challenges in our industry. See you in #Basel at #SwissBiotechDay!
AZAFAROS B.V.

1,591 followers
3mo

As a member of the Swiss Biotech Association, we are excited to join the many senior experts from the global life sciences industry at 🔜 #SwissBiotechDay at Basel Congress Centre next week. 📆On Monday, AZAFAROS B.V. CEO, Stefano Portolano, MD, will give a presentation during the "Clinical Stage Biotech Companies Track" session, which will take place at 🕞15:30 in the 📌 Samarkand Room. Our Head of Business Development, Giulia Vestri, Ph.D., MBA, will also join the conference to engage with investors and network with other attendees. As a clinical-stage biotech company with most of its staff based in Basel, we are really looking forward to sharing the progress of our lead asset, #nizubaglustat, with industry experts at this prestigious local event. We are making progress with our program to develop treatment options for patients with #GM1, #GM2 and Niemann-Pick Disease Type C (#NPC), and are looking forward to sharing the data of our completed RAINBOW study later this year https://lnkd.in/e5H5yzWH.  #SwissBiotech, #Azafaros, #collaboration, #innovation, #biotech, #networking, #investors, #rarediseases, #GM1, #GM2, #NPC
1 Comment
Like Comment
To view or add a comment, sign in
Fern Lazar

Entrepreneur. Champion of health innovation, women's health and better access to health resources.
10mo
Report this post
#digitalhealth attracted huge amounts of investment over the last several years. Recently there has been a shakeout of early entrants and a sharper focus on investment thesis. Want to know what’s next? Tune in to hear @Gil Bashe and other experts opine on what to watch in the future in this @Galen Growth webinar.
Gil Bashe

Voice for innovation and people's and the planet's health with @finnpartners | @medikalife | @HCNowRadio | @GalienFdn. Championing #biopharma #climatetech #digitalhealth #ecohealth #healthinnovation
10mo

Thursday, September 7th, at 12 noon ET - Experts will outline the future of #digitalhealth investment and the category criteria for success. Four leaders will share analyses, experience from the trenches and a #healthtech industry-wide overview: - David Benshoof Klein, CEO and Founder, Click Therapeutics, Inc. - Stan Kachnowski PHD MPA, Chair HITLAB at Columbia University - Sara Schmachtenberg, Global Analytic Lead, Galen Growth | Insights You Can Trust - Julien de Salaberry, Founder and CEO, Galen Growth | Insights You Can Trust Register Here: https://bit.ly/45K5Ef4 RSVPs will receive the full Galen Growth data report. Ansley Bowen, MPH, Jennifer Goldsack, John Lynn, Colin Hung, Levi Shapiro, Mendel Erlenwein, CNS Summit, Decentralized Trials & Research Alliance (DTRA), Goel Jasper, Ellie Gorlin Hanson, Julian Tyndale-Biscoe, Ritesh Patel, Nate West, Beth Friedman, Olivia Schlabach, Cullen Burnell
Like Comment
To view or add a comment, sign in
Coulter Partners

8,291 followers
9mo
Report this post
Meet Nanna Soni and Jelena Dukic Grubovic at the annual LSX - partnering for Life Science eXecutives Nordic Congress on 10-11 October 2023, in Copenhagen. Coulter Partners is proud to be sponsoring the event. LSX Nordic Congress gathers the founders and CEOs of innovative biotech, medtech and healthtech start-ups through to healthcare giants, and everyone in between. They attend alongside the sector’s most active investors, pharma, medtech and healthtech BD&L teams and R&D leaders. Book a meeting with Nanna and Jelena using the 1-2-1 partnering system. Nanna will be moderating the panel “Effective Talent Acquisition And Retention Strategies For Life Sciences In The Nordics.”: • What are the best practices for Nordic companies to increase recruitment of non-Nordic employees? • What strategies can companies employ to thrive in a competitive market and achieve growth? • How can organizations address talent-related issues and optimize their global talent and team structure to attract and retain top talent? • How can we continue to showcase the Nordic life sciences as a top environment for new career opportunities and development? The expert panelists are Jeroen Bakker, Principal Seed Investment, Novo Holdings; Annette Säfholm, CEO, Geada Biotech; Christina Herder, Member of the Board, Elicera Therapeutics & Beactica AB Find out more here: www.lsxleaders.com/Nordic #LSXNordic #lifescience #biotech #medtech #healthtech #digitalhealth #networking
Like Comment
To view or add a comment, sign in
Marcel Kaminstein

International Relations | Board Member: Kaminstein Family Office, MediaLab, American Club Rome, Grandmother Project, ProBusinessPAC
8mo
Report this post
🔬 Celebrating the Success of BIO Europe Conference 2023 in Munich Germany! (Next stop BIO Intl Convention Boston June 3-6 2024 ☀️San Diego.) Thrilled to have been part of the vibrant discussions and groundbreaking insights at the BIO Europe Conference. It showcased the incredible strides in biotech innovation that are shaping the future of healthcare. Biotech isn't just about science; it's about transforming lives. The innovations discussed here have the power to revolutionize medicine, addressing unmet needs and improving patient outcomes. As we navigate a rapidly evolving world, the significance of biotech innovation has never been clearer. Investing in biotech means investing in a healthier, more sustainable future. It's a catalyst for progress, driving advancements that impact us all. Let's continue to support and champion biotech innovation—it's not just a field; it's a lifeline to a better tomorrow. Thanks to all the Team at Informa, EBD Group, Sponsors and Biotechnology Innovation Organization 🧬💡 #bioeurope #healthcarerevolution
Like Comment
To view or add a comment, sign in
Consonance

1,523 followers
9mo
Report this post
🔓 "Unlocking a Healthier Tomorrow: Polish & British Innovation in Healthcare" was a fantastic chance to bridge the worlds of science and business. 🎙️ Paweł Zieliński shared our point of view on #MedTech projects and how we strive to transfer an idea into a successful medical product! Watch a short video report. Thank you Polish Investment and Trade Agency (PAIH) & Rafal Owczarek #medtech #UK #poland #partnership #biotech

Karol Cienkus, Ph.D.

Head of Economic Section/Embassy of the Republic of Poland in London
9mo

A few days ago we were pleased to host a group of Polish #biotech and #medtech companies at the Royal Society of Medicine in London during the event "Unlocking a Healthier Tomorrow: Polish & British Innovation in Healthcare". It was a great opportunity to connect scientific and business community - as nowhere else than in medicine bonds between science and business are so mutually reinforcing. Big thanks to all the speakers and panellists, including the Vice President of the Polish Medical Research Agency Rafał Staszewski and renowned Professor of Medical Genetics at the University of Aberdeen, Professor Zosia Miedzybrodzka, as well as distinguished guest from UK's medical ecosystem (Piers Ricketts, Eastern AHSN Academic Health Science Network, Julia Wilson Wellcome Sanger Institute). Strong representation of Polish companies (Genomtec S.A., WPD Pharmaceuticals Inc, BIOTON S.A., FiLeClo, Cellivia, Nivalit, SyVento sp. z o.o. , Ardigen, Consonance and BD Polska) as well as heads of Poland's largest biotech industry organisations (Magdalena Kulczycka,Ph.D. of Central European BioForum and Marta Winiarska of BioInMed ) proved that we have a lot to offer when it comes to world-class, cutting-edge biotech and medtech solutions! Polish Investment and Trade Agency (PAIH) Rafal Owczarek Bartosz Wiśniewski Marceli Ragan Alexandra Smith IQVIA Lukasz Rzeczkowski LinkGevity, Boleslaw Charles W. Marzena Kwasna, MBA Joanna Kobalczyk
Like Comment
To view or add a comment, sign in
Vienna BioCenter

16,620 followers
1mo
Report this post
G.ST Antivirals attended the #MTF2024 and talked to LISAvienna Guido Gualdoni, MD, PhD, CEO and co-founder of G.ST Antivirals shared insights about his career, the focus of his company, the Vienna Business Agency’s StartupLabs and funding programs for early-stage biotech companies in Austria such as those provided by Austria Wirtschaftsservice (aws) and FFG Austrian Research Promotion Agency. Learn more ⤵ #partofviennabiocenter #lisavienna #lifescience

LISAvienna

8,089 followers
1mo

At #MTF2024 in #Vienna we met Guido Gualdoni, MD, PhD, CEO and co-founder of G.ST Antivirals at the LISA - Life Science Austria networking booth. In this video he talks about his career, the focus of his company, the Vienna Business Agency’s #StartupLabs and funding programs for early-stage #biotech companies in #Austria such as those provided by Austria Wirtschaftsservice (aws) and FFG Austrian Research Promotion Agency. Watch the clip and also learn more about the conferences and partnering meetings where you can meet this company - including #BIOEurope in Stockholm in November. Did you know that LISAvienna is organizing the joint Austrian booth for this partnering conference? The number of discounted LISA packages is limited - first come, first served. Thank you, Guido, for you update on G.ST Antivirals. We are delighted that you value Vienna as a location for innovation. All the best for your team’s next steps. Additional information on this Vienna-based company is available at its website: https://lnkd.in/dEs3kV_p G.ST Antivirals is a #spinoff from Medizinische Universität Wien, a member of BIOTECH AUSTRIA, and located at the Vienna BioCenter. Learn more about the Vienna BioCenter here: https://lnkd.in/df3JdmWi, follow this link for new technologies and #startup companies with a connection to MedUni Vienna https://lnkd.in/dJFyTfqE and explore BIOTECH AUSTRIA’s member list online https://lnkd.in/dVdMFXJd ViennaBusiness | ABA - INVEST in AUSTRIA | AUSSENWIRTSCHAFT AUSTRIA #innovation #infectiousdiseases #antivirals #lifesciences Watch on YT: https://lnkd.in/dpR_i8Wx
Like Comment
To view or add a comment, sign in
Patrik Frei
4mo
Report this post
So Many Conferences — So Little Time: Which Conference to Visit? I often get asked by companies and industry stakeholders which conferences they should visit or which are worth attending in the first half of the year. I have been in the circle for 25 years now and there is no straight answer. The standard response is, it depends on what you are looking for. If you are looking for general partnering, there are a number of big conferences like the BIO International Convention and "#bioeuropespring", where you can meet people from all over the world. However, there are also some (smaller) regional-focused conferences like the "Swiss Biotech Day #swissbiotechday", which has grown to over 1,800 participants, or the "Asia Bio Partnering Forum #ASIABIO" and BIO KOREA. There are also therapeutic or technology-focused conferences like Advanced Therapies in London, Festival of Biologics in San Diego, or The World Vaccine Congress in DC. If you are fundraising, there are options like the BIO CEO & Investor Conference in NY for more mature (public) companies, "RESI Conferences Life Science Nation (LSN) (Atlanta and Barcelona) for earlier stage (private) companies, as well as LSX World Congress in London or The Annual European Life Sciences CEO Forum #Sachs_ELSF" in Zurich. Additionally, different investment banks host conferences, of which "JPM by JPMorgan Chase & Co." in San Francisco is where the industry meets. For very intimate interactions with other Biotech CEOs, I can recommend the "Biotech CEO Summit CEO Summit by Demy-Colton" in Barcelona and La Jolla. You can find all these conferences, along with their dates and links here https://lnkd.in/dawnkF6p

Upcoming Conferences in the Life Sciences Industry

biotechgate.com

2 Comments
Like Comment
To view or add a comment, sign in

2,284 followers

View Profile Follow

MUVON Therapeutics AG’s Post

More Relevant Posts

Swiss Biotech Day 2023 - Eventfilm

https://www.youtube.com/

Explore topics